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Abstract Myotonia congenita is an inherited disorder of
sarcolemmal excitation leading to delayed relaxation of skeletal
muscle following contractions. Mutations in a skeletal muscle
voltage-dependent chloride channel, ClC-1, have been identified
as the molecular genetic basis for the syndrome in humans, and in
two well characterized animal models of the disease: the
myotonic goat, and the arrested development of righting (adr)
mouse. We now report the molecular genetic and electrophysio-
logical characterization of a canine ClC-1 mutation that causes
autosomal recessive myotonia congenita in miniature Schnau-
zers. The mutation results in replacement of a threonine residue
in the D5 transmembrane segment with methionine. Functional
characterization of the mutation introduced into a recombinant
ClC-1 and heterologously expressed in a cultured mammalian
cell line demonstrates a profound effect on the voltage-
dependence of activation such that mutant channels have a
greatly reduced open probability at voltages near the resting
membrane potential of skeletal muscle. The degree of this
dysfunction is greatly diminished when heterodimeric channels
containing a wild-type and mutant subunit are expressed together
as a covalent concatemer strongly supporting the observed
recessive inheritance in affected dog pedigrees. Genetic and
electrophysiological characterization of the myotonic dog
provides a new and potentially valuable animal model of an
inherited skeletal muscle disease that has advantages over
existing models of myotonia congenita.
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1. Introduction
Myotonia congenita is an inherited condition characterized
by delayed relaxation of skeletal muscle after voluntary con-
traction without associated symptoms of weakness or muscu-
lar dystrophy [1]. The disease may be transmitted as either an
autosomal dominant (Thomsen’s disease) or recessive (reces-
sive generalized myotonia) trait. Recent molecular genetic
studies have identi¢ed the CLCN1 gene encoding the skeletal
muscle voltage-dependent chloride channel, ClC-1, as respon-
sible for this condition in human, mouse, and goat forms of
the disease [2^5].
Appropriate animal models of inherited human diseases are
important for understanding pathophysiology and for testing
new therapies. Presently, there are two well characterized ani-
mal models of myotonia congenita. The myotonic goat pro-
vided the ¢rst opportunity to de¢ne the cellular defect in
myotonic muscle. Seminal work by Bryant and colleagues,
¢rst demonstrated that muscle ¢bers from myotonic goats
exhibit greatly diminished chloride conductance, and that
this leads directly to hyperexcitability and a characteristic
after-depolarization associated with elevations in transverse
tubular potassium concentration [6,7]. The molecular defect
in the myotonic goat, a missense mutation in the carboxy
terminus of ClC-1 described by Beck et al., reduces channel
open probability at physiologic voltages by altering the volt-
age-dependence of channel activation [5]. Transmission of the
myotonic phenotype in the goat is autosomal dominant. The
only other characterized animal model of myotonia congenita
is the adr (arrested development of righting) mouse [8]. In this
animal, autosomal recessive transmission of a severe myotonic
phenotype has been linked to the disruption of the murine
ClC-1 gene by insertion of a transposon element [4]. Other
myotonic mouse variants also exist due to non-sense or mis-
sense mutations in the same chloride channel gene [9]. Both
animal models have signi¢cant disadvantages for studying the
physiologic impact of new therapies. Because of its size, cer-
tain experimental manipulations, such as performing electro-
myography, are tedious in the adr mouse. Furthermore, the
myotonic mouse exhibits a high mortality rate in the early
postnatal period. The myotonic goat is also di⁄cult to manip-
ulate and maintain. Other animal models more suitable to
testing new therapeutic maneuvres are clearly important to
identify.
Congenital myotonia has been observed in certain dog
breeds, and Vite et al. recently described this phenotype in
miniature Schnauzers [10]. Myotonia in this dog breed exhib-
its many of the same features as human myotonia congenita
including moderate to severe action myotonia, muscle hyper-
trophy, decreased myotonia severity with continued activity
(‘warm-up’), and low sarcolemmal chloride conductance.
In this report we delineate a missense mutation in canine
ClC-1 that is associated with autosomal recessive transmission
of the phenotype in myotonic dogs. The mutation is located
near recently identi¢ed pore forming segments in ClC-1 [11]
and causes a profound shift in the voltage-dependence of ac-
tivation. This altered voltage-dependence of activation sub-
stantially decreases channel open probability at physiologic
voltages and fully explains the reduced macroscopic chloride
conductance responsible for the observed sarcolemmal hyper-
excitability. These ¢ndings provide molecular genetic charac-
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terization of a new and potentially valuable animal model for
studying an inherited human muscle disease.
2. Materials and methods
2.1. Isolation of RNA
Skeletal muscle was obtained from a phenotypically and electro-
myographically normal pure-bred miniature Schnauzer (wild-type,
WT) and from a myotonic miniature Schnauzer. Total RNA was
isolated with Trizol (Life Technologies, Gaithersberg, MD, USA) ac-
cording to the supplier’s instructions.
2.2. Northern blot analysis
Total RNA (20 Wg) from WT and myotonic muscle was size-frac-
tionated on denaturing 1% agarose/1UMOPS-EDTA/6% (vol/vol)
formaldehyde gels and transferred to a nylon membrane (Hybond-
N, Amersham). The blot was probed with a [32P]dCTP-labeled anti-
sense RNA probe transcribed from human ClC-1 cDNA (nt 1^1419)
using SP6 RNA polymerase. Hybridization was performed at 50‡C
for 20 h in 50% formamide/5USSPE (1USSPE is 0.18 M NaCl,
10 mM Na2HPO4, 1 mM EDTA)/1% SDS/0.2% Ficoll/0.2% polyvi-
nylpyrrolidone/2 mM sodium pyrophosphate/0.3 mg/ml denatured sal-
mon sperm DNA with a 32P-labeled hClC-1 RNA probe at 2U106
cpm/ml, followed by washes in 0.1USSPE/0.1% SDS at 60‡C.
2.3. Isolation and cloning of canine ClC-1 cDNA
A commercially available dog skeletal muscle cDNA library con-
structed in VZapII (Stratagene) was screened using standard methods
[12]. Duplicate plaque lifts were hybridized at 42‡C for 16 h in 50%
formamide/5USSPE/4UDenhardt’s solution/1% SDS/0.3 mg/ml dena-
tured salmon sperm DNA with 32P-labeled hClC-1 cDNA (NotI-
EcoRV fragment, nt 1^796) at 0.6U106 cpm/ml. Positive clones
were plaque puri¢ed, in vivo excised as pBluescript phagemids, and
sequenced by dideoxynucleotide-mediated chain-termination using £u-
orescent dye-terminator chemistry (Perkin-Elmer/Applied Biosys-
tems).
2.4. Single-strand conformational analysis
Total RNA (3 Wg) was randomly primed for ¢rst-strand cDNA
synthesis. Subsequently, double-stranded cDNAs were ampli¢ed
with each of the primer sets described in Table 1.
Ampli¢ed products were denatured, electrophoresed on 0.5 MDE
gels at 3 W for 14.5 h at 25‡C, and visualized by silver staining.
Abnormal conformers were excised, reconstituted in water for ream-
pli¢cation, and sequenced with both the respective forward and re-
verse primers using £uorescent dye-terminator chemistry.
2.5. Allele-speci¢c oligonucleotide hybridization
Whole blood samples were obtained from 45 normal mixed breed
dogs. Genomic DNA was extracted using QIAamp spin columns
(Qiagen) and used in PCR ampli¢cations containing the following
oligonucleotides: 747F, 5P-GCGGTCCTCAGCAAGTTT-3P and
818R, 5P-AACAACAGCCAACTCCTA-3P. The ampli¢ed products
were denatured and transferred to a nylon membrane (Hybond-N,
Amersham) utilizing a slot-blot apparatus (Minifold II, Schleicher
and Schuell). The blot was hybridized for 1 h at 46‡C in 5USSPE/
4UDenhardt’s solution/1% SDS with a 32P-labeled mutant oligonu-
cleotide (793FM: 5P-GACATGCTGATGGTG-3P) at 0.6U106 cpm/
ml. After autoradiographic detection of the mutant allele, the blot was
stripped then rehybridized with an oligonucleotide matching the WT
sequence (793FWT: 5P-GACATGCTGACGGTG-3P).
2.6. Site-directed mutagenesis and construction of heterodimers
Site-speci¢c mutagenesis of hClC-1, concatemeric hClC-1 construc-
tion, and transient transfection of tsA201 cells were performed as
previously described [13]. Brie£y, the mutation T268M was con-
structed in hClC-1 using a single-step polymerase chain reaction mu-
tagenesis strategy. Primers were designed to create the desired muta-
tion and incorporate natural restriction sites for ApoI (nt. 742) and
BsteII (nt. 873) in the ¢nal product. Ampli¢cations (20 cycles) were
performed using 20 ng of hClC-1 cDNA as template and Taq DNA
polymerase. Final products were puri¢ed by spin-column chromatog-
raphy (Qiagen), digested with ApoI and BsteII, and the resulting
131 bp fragment ligated into the corresponding sites in the plasmid
pRc/CMV-hClC-1. The ampli¢ed region was sequenced entirely in the
¢nal construct to verify the mutation and to exclude polymerase er-
rors. A tandem construct (WT-T268M) containing both WT-hClC-1
and T268M in the same open reading frame was constructed by the
approach previously described [13].
2.7. Electrophysiological recording
WT and mutant hClC-1 channels were either stably expressed in
HEK-293 cells [14] or transiently expressed in tsA201 cells (HEK-293
cells stably transformed with the SV40 large T antigen) using calcium
phosphate transfection [15]. Current recordings were made using the
whole-cell or the excised inside-out con¢guration of the patch clamp
technique as previously described [16]. The bath solution contained (in
mM): 140 NaCl, 4 KCl, 2 CaCl2, 1 MgCl2, and 5 HEPES. The pipette
solution contained (in mM): 130 NaCl, 2 MgCl2, 5 EGTA,
10 HEPES. All solutions were adjusted to pH 7.4 with NaOH.
To construct activation curves, the instantaneous current amplitude
divided by its maximum value at a ¢xed test potential measured after
1.4 s prepulses to di¡erent voltages (V) was plotted vs. the preceding
potential as described previously [14]. This plot yields the voltage-
dependence of the relative open probability, Popen. The activation
curves obtained in this manner were ¢t with a single Boltzmann
and a voltage-independent value: I(V) = AmpW[1+exp([V3V0:5]/
kV)]31+constant.
Instantaneous whole-cell currents were determined after a 200 ms
prepulse to +75 mV. Using these data, the voltage-dependence of the
instantaneous whole-cell chloride conductance (g), a value proportion-
al to the single channel conductance, was calculated from
g(V) = [I(V+5 mV)3I(V35 mV)]/10 mV. The equation g(V) = gmax/
(1+exp[(V3V0:5)/kV] was ¢t to the experimental data [14].
3. Results and discussion
To verify the presence of an mRNA transcript encoding
canine ClC-1, and to exclude large scale gene disruptions as
a cause for myotonia, we performed Northern blot analysis of
total RNA from myotonic and wild-type (WT) dogs using a
Table 1
Oligonucleotide primer pairs used in canine ClC-1 mutation screening
Set Forward primer Reverse primer
1 88F: 5P-TTCAACACAGGCTCCACAGG-3P 227R: 5P-ATCCTCATCCTTGCTGTCCA-3P
2 172F: 5P-TCAGACAAGGAGCAGGACAC-3P 319R: 5P-CCCAGGAGCACCAGAAAGAT-3P
3 290F: 5P-TGGTGAGAAGAAAGTTAGGA-3P 459R: 5P-TGAGAGTTAGCGGGAAGGTG-3P
4 416F: 5P-ACCAGATGCAGCCCAACCTG-3P 598R: 5P-GGCCACAACCTTGCCACAAA-3P
5 537F: 5P-CCCTGAAATGAAGACAATAC-3P 717R: 5P-TCATAGACCCCACAGAACAT-3P
6 627F: 5P-GGGCTGGGCAGTGGCATTC-3P 847R: 5P-TTCCGCACAGCAAAGTATG-3P
7 811F: 5P-TTGGAGGAGTGTTGTTCAGC-3P 1020R: 5P-CCACAGCAAATCCCGATGAT-3P
8 915F: 5P-GTGCTGGCCGTGTGGAACA-3P 1108R: 5P-CTTCGCCAGAAATTGGCTGA-3P
9 1044F: 5P-CTGGGAGCCGTGTTTGTGTA-3P 1232R: 5P-TGTCGAATAGGGTGCTGATG-3P
10 1211F: 5P-AGAGTTGATGCCTCGTGAAG-3P 1439R: 5P-TCCTACCAGCCTCCCAAATG-3P
11 1412F: 5P-TCATGCCTGTGTTTGTGCTA-3P 1564R: 5P-GAGACTGTGTGGGATACTGC-3P
12 1522F: 5P-CCTGGAGGCTATGCGGTAAT-3P 1702R: 5P-AGCTTCTTGACCTGGATGAT-3P
13 1680F: 5P-GCAGCCCTCCCTCTATGAC-3P 1822R: 5P-TTCGCAATTCCCCGTATGT-3P
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radiolabeled cDNA probe derived from human ClC-1 (hClC-
1, nucleotides 1^1419). Under conditions of moderate strin-
gency we observed a ~4.0 kb speci¢c hybridization signal of
approximately equal intensity, in both WT and myotonic dog
muscle RNA (data not shown). These data suggest that a
major disruption of the canine ClC-1 gene was not the likely
cause of myotonia in this animal.
We next isolated a single 1.9 kb cDNA clone from a dog
muscle cDNA library and determined its sequence using a
primer walking strategy. The complete nucleotide sequence
of the clone revealed a high degree of nucleotide sequence
identity with rat and human ClC-1 (87% human, 83% rat),
and signi¢cantly less sequence identity with other known ClC
isoforms (60% rat ClC-2, 33% rat ClC-3). The nucleotide se-
quence of the dog clone corresponds to regions of hClC-1
encoding all predicted transmembrane domains and recently
identi¢ed pore forming segments.
Using the information obtained from sequencing the partial
length dog ClC-1 cDNA, we designed a panel of PCR primer
pairs (Table 1) for use in mutation screening using single-
strand conformational analysis [17]. Total RNA samples
from both myotonic and WT dog muscle were subjected to
reverse transcription-PCR using each primer pair, and the
resulting set of overlapping products were electrophoresed in
non-denaturing MDE gels overnight. Gel migration patterns
were resolved by silver staining and were inspected for aber-
rant conformers. Products produced by primer pair 6 exhib-
ited electrophoretic di¡erences between myotonic and WT
dog. The distinct conformers from WT and myotonic dog
samples were isolated, reampli¢ed, and the products puri¢ed
for sequence analysis. Sequencing revealed a C to T transition
predicting the replacement of a threonine residue (ACG co-
don) by methionine (ATG codon) in the myotonic dog ClC-1.
Based on sequence alignments, this threonine residue corre-
sponds to threonine-268 in hClC-1 and is predicted to lie
within the amino-terminal region of the D5 transmembrane
segment. Threonine, serine, or alanine occupies this respective
position in most known ClC isoforms (Fig. 1), and therefore
we considered this a candidate mutation. The nucleotide tran-
sition occurs in the context of a mutation prone CpG dimer
[18].
If the threonine to methionine substitution (designated as
T268M based on the hClC-1 amino acid numbering scheme) is
indeed the disease-producing mutation, then we would expect
it to cosegregate with the disease phenotype in a¡ected dog
pedigrees. Unfortunately, the parents of the myotonic dog
from whom the muscle tissue was obtained could not be iden-
ti¢ed, and we therefore ascertained additional myotonic ani-
mals from a breeder. Breeding studies of other myotonic dogs
indicate an autosomal recessive mode of inheritance [21], and
we used an allele-speci¢c hybridization assay using PCR am-
pli¢ed genomic DNA to perform genotype analysis. Four
myotonic dogs from one three generation pedigree were ho-
Fig. 1. Comparison of ClC-1 amino acid sequence in WT and myo-
tonic dogs. Amino acid alignment of several ClC isoforms in the re-
gion containing the myotonic dog mutation (GenBank accession
numbers for aligned sequences: rat ClC-1, X62894; Torpedo, ClC-0,
X56758; rat ClC-2, X64139; rat ClC-3, D17521; yeast GEF1,
Z23117; ClC-Nt1, X95576). The amino acid sequence of the dog
ClC-1 is a partial sequence and therefore the residue numbering is
not co-linear with rat ClC-1.
Fig. 2. Electrophysiological characterization of WT-hClC-1 and T268M. Whole-cell current recordings from tsA201 cells transfected with either
WT-hClC-1 (A) or T268M (B). Currents were recorded in response to a series of test potentials ranging from 3165 to +75 mV in 40 mV steps
from a holding potential of 0 mV (pulse protocol illustrated above panel A). Representative current-voltage relationships for WT-hClC-1 (C)
and T268M (D) are shown for both ‘instantaneous’ (b) and steady-state (P) current amplitudes (‘instantaneous’ current amplitudes are de¢ned
as the current recorded 400 Ws after the onset of the test potential).
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mozygous for the mutation, and two non-myotonic obligate
carriers were found to be heterozygous for the allele. The
allele was not present in 45 unrelated non-myotonic dogs of
various breeds. The presence of a nucleotide substitution af-
fecting a conserved amino acid, its consistent presence in all
myotonic dogs ascertained and its absence in normal animals,
strongly support that this is the disease producing mutation.
To further demonstrate that the mutation critically a¡ects
the function of the muscle chloride channel consistent with
myotonia, we performed functional studies using the recombi-
nant hClC-1 cDNA heterologously expressed in a cultured
mammalian cell line (tsA201). We introduced the mutation,
T268M, into hClC-1, transfected this into tsA201 cells, and
used whole-cell patch clamp recording to characterize its func-
tional properties. Fig. 2 illustrates a comparison of whole-cell
current records and current-voltage relationships for WT and
mutant hClC-1. The mutant exhibits an altered voltage-de-
pendence of channel gating manifest by slight changes in the
time course of deactivation at strongly negative test potentials
(Fig. 2B), changed voltage-dependence of the late current am-
plitude (Fig. 2D), and a time-dependent increase of the cur-
rent amplitude upon voltage steps to positive potentials (Fig.
2B). Pore properties were only minimally a¡ected by the
T268M mutation. Ion selectivity determined from permeabil-
ity ratios measured under biionic conditions [15] was altered
slightly in the mutant (WT-hClC-1: Cls SCNsBrs
NO3s I; vs. T268M: SCNsClsBrsNO3 = I). Further-
more, the voltage-dependence of the unitary conductance in-
ferred from the instantaneous conductance-voltage relation-
ship was unchanged (data not shown).
The voltage-dependence of the relative channel open prob-
ability was tested by recording instantaneous current ampli-
tudes following a 1.4 s prepulse to various voltages, and plot-
ting the recorded normalized current as the relative open
probability at the end of the prepulse (Fig. 3). For WT and
T268M, these curves can be ¢t with a single Boltzmann plus a
voltage-independent value denoting the minimum open prob-
ability at very negative potentials. Neither the slope factors
(WT: 23.1 þ 0.6 mV, n = 4; T268M: 21.1 þ 0.3 mV, n = 4) nor
the voltage-independent minimum values (WT: 0.09 þ 0.01,
n = 4; T268M: 0.06 þ 0.01, n = 4) were di¡erent between WT
and T268M. By contrast, the midpoint of activation of
T268M exhibits a 81 mV shift toward the positive potential
range in comparison to WT (T268M = 32.1 þ 0.4 mV vs.
WT =349.5 þ 0.7 mV, n = 4) (Fig. 3A). This dramatic shift
results in a diminished open probability at voltages near the
resting membrane potential of mammalian skeletal muscle. In
a physiologic context this biophysical defect will result in a
greatly diminished sarcolemmal chloride conductance in the
physiologic voltage range. A similar phenomenon has been
described for mutations associated with recessive [19], and
dominant myotonia congenita, including the myotonic goat
mutation [5,20].
The skeletal muscle chloride channel is a dimeric protein
[13], and we expect that a signi¢cant fraction of ClC-1 assem-
bly in heterozygous animals will result in heterodimers of WT
and mutant subunits. To determine the functional character-
istics of heterodimers and to discern whether the mutation is
functionally dominant or recessive, we constructed and ex-
pressed a concatemer of WT and T268M (WT-T268M) in a
single open reading frame. The tandem dimer gave rise to
functional chloride channels in tsA201 cells that strongly re-
semble those recorded from WT-hClC-1 (data not shown).
Despite the dramatic e¡ect of homodimeric T268M on the
voltage-dependence of activation, WT-T268M exhibits a
much smaller 13 mV shift in the midpoint of activation
(WT-T268M =336.9 þ 0.5 mV, n = 4, Fig. 3B). This ¢nding
suggests that the mutant does not exhibit a dominant negative
in£uence over the wild-type allele, and is consistent with re-
cessive inheritance.
Myotonia congenita is one of numerous inherited diseases
of skeletal muscle that have been de¢ned at the molecular
level in recent years. Although the disorder is rare and is
associated with only mild morbidity, it represents an ex-
tremely well characterized pathophysiological entity that has
provided a great deal of information regarding normal muscle
excitation and contraction. Newer drugs and possibly novel
genetic techniques require vigorous animal testing prior to
their deployment on human subjects. We have de¢ned the
molecular genetic basis for autosomal recessive myotonia con-
genita in a breed of miniature Schnauzers. Myotonia in this
animal is caused by a missense mutation in the canine ClC-1
chloride channel that causes a dramatic shift in the voltage-
dependence of its open probability. These ¢ndings establish
the myotonic dog as a potentially valuable new animal model
of this disease process, and we believe that it will be superior
to the existing models of myotonia congenita.
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